Paper36079151
Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic Strategies.
Yang T and 4 others. J Clin Med, 2022. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic Strategies. Papers, record 36079151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36079151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic Strategies.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 7202150 | Beijing Municipal Natural Science Foundation | PubMed | ||
| 19JCZDJC64200(Z) | Beijing 312 Municipal Natural Science Foundation | PubMed | ||
| 2016-I2M-2-001 | Chinese Academy of Medical 313 Sciences Innovation Fund for Medical Sciences | PubMed | ||
| 2019ZLH101 | Tsinghua University- 314 Peking Union Medical College Hospital Initiative Scientific Research Program | PubMed |
Source PubMed
References85
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29093005 | Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma. | Cancer Res | 2018 | https://conductscience.org/library/papers/29093005 | PubMed |
| 2 | 24353326 | Challenging cytomegalovirus data in glioblastoma. | Neuro Oncol | 2014 | https://conductscience.org/library/papers/24353326 | PubMed |
| 3 | 25877510 | Tetanus shot may improve glioblastoma treatment. | Cancer Discov | 2015 | https://conductscience.org/library/papers/25877510 | PubMed |
| 4 | 23297260 | The "silent" global burden of congenital cytomegalovirus. | Clin Microbiol Rev | 2013 | https://conductscience.org/library/papers/23297260 | PubMed |
| 5 | 27517625 | CMV70-3P miRNA contributes to the CMV mediated glioma stemness and represents a target for glioma experimental therapy. | Oncotarget | 2017 | https://conductscience.org/library/papers/27517625 | PubMed |
| 6 | 28821204 | Absence of CMV viremia in high-grade glioma patients under low dosage glucocorticoid treatment. | Neuro Oncol | 2017 | https://conductscience.org/library/papers/28821204 | PubMed |
| 7 | 26893852 | Valganciclovir and bevacizumab for recurrent glioblastoma: A single-institution experience. | Mol Clin Oncol | 2016 | https://conductscience.org/library/papers/26893852 | PubMed |
| 8 | 24404994 | Treatment of cytomegalovirus infections beyond acute disease to improve human health. | Expert Rev Anti Infect Ther | 2014 | https://conductscience.org/library/papers/24404994 | PubMed |
| 9 | 24004141 | Survival in patients with glioblastoma receiving valganciclovir. | N Engl J Med | 2013 | https://conductscience.org/library/papers/24004141 | PubMed |
| 10 | 28710491 | Ageing and latent CMV infection impact on maturation, differentiation and exhaustion profiles of T-cell receptor gammadelta T-cells. | Sci Rep | 2017 | https://conductscience.org/library/papers/28710491 | PubMed |
| 11 | 30027430 | A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model. | Neurotherapeutics | 2018 | https://conductscience.org/library/papers/30027430 | PubMed |
| 12 | 32719000 | Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma. | Clin Cancer Res | 2020 | https://conductscience.org/library/papers/32719000 | PubMed |
| 13 | 33166616 | Clinical practice guidelines for the management of adult diffuse gliomas. | Cancer Lett | 2021 | https://conductscience.org/library/papers/33166616 | PubMed |
| 14 | 32750039 | Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme. | J Clin Invest | 2020 | https://conductscience.org/library/papers/32750039 | PubMed |
| 15 | 19318640 | Activation of telomerase by human cytomegalovirus. | J Natl Cancer Inst | 2009 | https://conductscience.org/library/papers/19318640 | PubMed |
| 16 | 31868329 | Cytomegaloviruses and malignant brain tumors. | Exp Oncol | 2019 | https://conductscience.org/library/papers/31868329 | PubMed |
| 17 | 21036194 | Is HCMV a tumor promoter? | Virus Res | 2011 | https://conductscience.org/library/papers/21036194 | PubMed |
| 18 | 24248554 | Good maths is needed to understand CMV data in glioblastoma. | Int J Cancer | 2014 | https://conductscience.org/library/papers/24248554 | PubMed |
| 19 | 32987955 | Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma. | Microorganisms | 2020 | https://conductscience.org/library/papers/32987955 | PubMed |
| 20 | 25268364 | Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade. | PLoS One | 2014 | https://conductscience.org/library/papers/25268364 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42970103 | Cytomegalovirus and cancer stem cells: a hidden alliance in tumor progression and therapy resistance. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42970103 | PubMed |
| 41463341 | HCMV as an Oncomodulatory Virus in Ovarian Cancer: Implications of Viral Strain Heterogeneity, Immunomodulation, and Inflammation on the Tumour Microenvironment and Ovarian Cancer Progression. | Biomolecules | 2025 | https://conductscience.org/library/papers/41463341 | PubMed |
| 41366148 | Immunotherapy and targeted therapy for high grade gliomas: current and future directions. | J Neurooncol | 2025 | https://conductscience.org/library/papers/41366148 | PubMed |
| 41304872 | Cyclodextrin-Based Formulations as a Promising Strategy to Overcome the Blood-Brain Barrier: Historical Overview and Prospects in Glioblastoma Treatment. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41304872 | PubMed |
| 41070737 | hsa-miR-144-3p and hsa-miR-4262 are exosomal biomarkers and function as tumor suppressors in HCMV positive brain tumor. | Future Oncol | 2025 | https://conductscience.org/library/papers/41070737 | PubMed |
| 40909339 | A landscape review with novel criteria to evaluate microbial drivers for cancer: priorities for innovative research targeting excessive cancer mortality in sub-Saharan Africa. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40909339 | PubMed |
| 40806554 | Environmental Hazards and Glial Brain Tumors: Association or Causation? | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806554 | PubMed |
| 40676060 | Cytomegalovirus-induced oncomodulation drives immune escape in glioblastoma. | Sci Rep | 2025 | https://conductscience.org/library/papers/40676060 | PubMed |
| 40563634 | The Role of Viruses in the Glioma Tumor Microenvironment: Immunosuppressors or Primers for Anti-Tumor Immunity? | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40563634 | PubMed |
| 40514716 | Role of cytomegalovirus in glioblastoma development: promoter or culprit? | Virol J | 2025 | https://conductscience.org/library/papers/40514716 | PubMed |
| 39639257 | Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma. | BMC Med | 2024 | https://conductscience.org/library/papers/39639257 | PubMed |
| 39421709 | Early growth response 1 transcription factor and its context-dependent functions in glioblastoma. | Contemp Oncol (Pozn) | 2024 | https://conductscience.org/library/papers/39421709 | PubMed |
| 39340558 | Transient MRI changes and neurological deterioration in glioblastoma upon SARS-CoV-2 infection. | J Cancer Res Clin Oncol | 2024 | https://conductscience.org/library/papers/39340558 | PubMed |
| 39062747 | Cytomegalovirus in Adenoma and Carcinoma Lesions: Detecting Mono-Infection and Co-Infection in Salivary Glands. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39062747 | PubMed |
| 38921749 | The Role of Oncogenic Viruses in the Pathogenesis of Sporadic Breast Cancer: A Comprehensive Review of the Current Literature. | Pathogens | 2024 | https://conductscience.org/library/papers/38921749 | PubMed |
| 38672226 | Friend or Foe? Exploring the Role of Cytomegalovirus (HCMV) Infection in Head and Neck Tumors. | Biomedicines | 2024 | https://conductscience.org/library/papers/38672226 | PubMed |
| 38612552 | Human Cytomegalovirus Oncoprotection across Diverse Populations, Tumor Histologies, and Age Groups: The Relevance for Prospective Vaccinal Therapy. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612552 | PubMed |
| 38473776 | Glioblastoma Therapy: Past, Present and Future. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38473776 | PubMed |
| 38066255 | Ganciclovir as a potential treatment for glioma: a systematic review and meta-analysis. | J Neurooncol | 2023 | https://conductscience.org/library/papers/38066255 | PubMed |
| 36548694 | Challenges, Recent Advances and Perspectives in the Treatment of Human Cytomegalovirus Infections. | Trop Med Infect Dis | 2022 | https://conductscience.org/library/papers/36548694 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36079151
GET https://conductscience.org/api/papers/v1/36079151/references?page=2